Predicting Response to ICI Therapy Using ctDNA in Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma
Int. J. Urol. 2022 Feb 19;[EPub Ahead of Print], Y Koh, K Nakano, K Katayama, G Yamamichi, S Yumiba, E Tomiyama, M Matsushita, Y Hayashi, Y Yamamoto, T Kato, K Hatano, A Kawashima, T Ujike, R Imamura, R Yamaguchi, S Imoto, Y Shiotsu, N Nonomura, M UemuraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.